We are live on ! Find out more
AC

Arjuna Capital Portfolio holdings

AUM $393M
1-Year Est. Return 20.42%
This Fund
S&P 500
This Quarter Est. Return
+9.56%
1 Year Est. Return
+20.42%
3 Year Est. Return
+74.87%
5 Year Est. Return
+103.01%
10 Year Est. Return
–
AUM
$379M
AUM Growth
+$18.1M
Cap. Flow
-$6.43M
Cap. Flow %
-1.69%
Top 10 Hldgs %
49.64%
Holding
123
New
10
Increased
8
Reduced
91
Closed
6

Top Buys

Rank Stock Value
1
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$6.54M
2
TAK icon
Takeda Pharmaceutical
TAK
+$816K
3
JCI icon
Johnson Controls International
JCI
+$785K
4
MET icon
MetLife
MET
+$743K
5
KD icon
Kyndryl
KD
+$725K

Top Sells

Rank Stock Value
1
AMAL icon
Amalgamated Financial
AMAL
+$1.56M
2
MSFT icon
Microsoft
MSFT
+$1.04M
3
AAPL icon
Apple
AAPL
+$971K
4
TMO icon
Thermo Fisher Scientific
TMO
+$905K
5
NVDA icon
NVIDIA
NVDA
+$888K

Sector Composition

Rank Sector Weight
1 Technology 27.5%
2 Financials 13.3%
3 Consumer Discretionary 8.52%
4 Healthcare 8.48%
5 Communication Services 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESGV icon
51
Vanguard ESG US Stock ETF
ESGV
$13B
$1.71M 0.45%
15,610
-578
-4% -$58.3K
CAH icon
52
Cardinal Health
CAH
$54.5B
$1.68M 0.44%
9,995
-469
-4% -$69.6K
TGT icon
53
Target
TGT
$65.5B
$1.68M 0.44%
17,002
-675
-4% -$64.8K
BKNG icon
54
Booking.com
BKNG
$154B
$1.66M 0.44%
7,175
-300
-4% -$61.4K
SCHW
55
Charles Schwab
SCHW
$184B
$1.63M 0.43%
17,905
-956
-5% -$80K
DGX icon
56
Quest Diagnostics
DGX
$26B
$1.55M 0.41%
8,644
-687
-7% -$119K
CB icon
57
Chubb
CB
$141B
$1.53M 0.4%
5,289
-862
-14% -$248K
DIS icon
58
Walt Disney
DIS
$172B
$1.5M 0.4%
12,113
-662
-5% -$68.8K
HPQ icon
59
HP
HPQ
$25.9B
$1.45M 0.38%
59,380
-2,582
-4% -$65.8K
NVS icon
60
Novartis
NVS
$304B
$1.44M 0.38%
11,892
-555
-4% -$62.6K
COR icon
61
Cencora
COR
$62.2B
$1.43M 0.38%
4,758
-220
-4% -$63.4K
SNY icon
62
Sanofi
SNY
$109B
$1.41M 0.37%
29,161
-1,087
-4% -$55.5K
C icon
63
Citigroup
C
$222B
$1.4M 0.37%
16,475
-1,070
-6% -$77.3K
BBY icon
64
Best Buy
BBY
$18.9B
$1.39M 0.37%
20,714
-919
-4% -$62.4K
VRTX icon
65
Vertex Pharmaceuticals
VRTX
$124B
$1.38M 0.37%
3,110
-890
-22% -$410K
BNY
66
Bank of New York Mellon
BNY
$106B
$1.37M 0.36%
15,028
-798
-5% -$67.8K
NUE icon
67
Nucor
NUE
$60.5B
$1.36M 0.36%
10,490
-503
-5% -$58.8K
LECO icon
68
Lincoln Electric
LECO
$14.6B
$1.32M 0.35%
6,351
-313
-5% -$59.9K
STT icon
69
State Street
STT
$50.2B
$1.29M 0.34%
12,101
-83
-0.7% -$7.68K
RGA icon
70
Reinsurance Group of America
RGA
$15.9B
$1.28M 0.34%
6,475
-344
-5% -$67.2K
SYY icon
71
Sysco
SYY
$40.8B
$1.24M 0.33%
16,368
-773
-5% -$56.1K
PG icon
72
Procter & Gamble
PG
$347B
$1.24M 0.33%
7,771
-339
-4% -$55.3K
VMI icon
73
Valmont Industries
VMI
$9.33B
$1.21M 0.32%
3,710
-171
-4% -$52.4K
CTSH icon
74
Cognizant
CTSH
$23.8B
$1.18M 0.31%
15,140
-739
-5% -$56.6K
CRM icon
75
Salesforce
CRM
$149B
$1.17M 0.31%
4,300
-211
-5% -$56.4K
1 2
3
4 5

Similar funds

IAG
Investment Advisory Group Hanover, Massachusetts $393M AUM 16.75% 1-Year Est. Return
T
Tidemark San Diego, California $393M AUM 16.18% 1-Year Est. Return
SILC
Starr Indemnity & Liability Company New York $394M AUM 37.48% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return
RWA
Roberts Wealth Advisors Palo Alto, California $394M AUM 21.35% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
RC
Riposte Capital New York $392M AUM 69.08% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

Arjuna Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Arjuna Capital held 123 positions worth $379M, up 5% from $361M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Arjuna Capital's Q2 2025 filing shows 10 new, 8 increased, 91 reduced and 6 closed positions. Its largest new stake was Takeda Pharmaceutical: 55,222 shares worth $854K. The largest sale was Amalgamated Financial, an estimated $1.56M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Arjuna Capital's largest Q2 2025 buy was Takeda Pharmaceutical: 55,222 shares worth $854K.
  • Arjuna Capital added most to iShares 0-3 Month Treasury Bond ETF in Q2 2025, an estimated $6.54M increase.
  • Arjuna Capital's biggest Q2 2025 reduction was Amalgamated Financial, cutting an estimated $1.56M.
  • Arjuna Capital fully exited Apogee Enterprises in Q2 2025, selling an estimated $706K.
  • Arjuna Capital's ten largest holdings make up 50% of its $379M portfolio in Q2 2025.
  • Arjuna Capital opened 10 new positions and closed 6 in Q2 2025.
  • Arjuna Capital's portfolio value rose 5% quarter-over-quarter to $379M.

Based on Arjuna Capital's 13F filing for Q2 2025, filed 13 Aug 2025.